<code id='73843784BD'></code><style id='73843784BD'></style>
    • <acronym id='73843784BD'></acronym>
      <center id='73843784BD'><center id='73843784BD'><tfoot id='73843784BD'></tfoot></center><abbr id='73843784BD'><dir id='73843784BD'><tfoot id='73843784BD'></tfoot><noframes id='73843784BD'>

    • <optgroup id='73843784BD'><strike id='73843784BD'><sup id='73843784BD'></sup></strike><code id='73843784BD'></code></optgroup>
        1. <b id='73843784BD'><label id='73843784BD'><select id='73843784BD'><dt id='73843784BD'><span id='73843784BD'></span></dt></select></label></b><u id='73843784BD'></u>
          <i id='73843784BD'><strike id='73843784BD'><tt id='73843784BD'><pre id='73843784BD'></pre></tt></strike></i>

          Home / knowledge / explore

          explore


          explore

          author:knowledge    Page View:7114
          IQVIA signage. -- health tech coverage from STAT
          Adobe

          The health data giant IQVIA became a dominant force by gobbling up its rivals. Over decades, it feasted on upstarts with new datasets or novel technologies, growing into a juggernaut with no peer in the business of brokering Americans’ medical information.

          Now, government regulators say, IQVIA’s appetite for acquisition is getting out of control — and must be reined in.

          advertisement

          A Federal Trade Commission lawsuit seeking to block its acquisition of the digital advertising firm DeepIntent marks a crossroads for the company and the multi-billion dollar medical advertising economy it serves. The agency, which is seeking an injunction and temporary restraining order in federal court, argues that IQVIA’s data vault has become so large — and revealing — that it forms the substrate of an entire industry focused on showering doctors and patients with marketing messages.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In